Why the study?
E-cigarettes are advertised as less harmful and helpful for smoking cessation, but cause vascular damage and have controversial utility, prompting an overview to optimize treatment and medical counselling.
This position statement emphasizes that e-cigarettes are not risk-free and cause vascular damage, advising caution regarding their use for smoking cessation.
E-cigarette use warrants caution in CVD prevention; challenges harm-reduction claims and extends vascular risk data.
Tobacco consumption is one of the most important risk factors for cardiovascular disease. Despite all efforts to curb any form of smoking, the number of e-cigarette users is still rising more than tabacco smoking decreases. E-cigarettes are often advertised as less harmful than regular cigarettes and helpful for smoking cessation. But e-cigarettes are not risk-free and their use causes vascular damage. There is concern about long-term health risks of e-cigarettes or when non-smokers use them as first nicotine contact. Furthermore, their use for smoking cessation is discussed controversially. To optimize treatment and medical counselling of current smokers and e-cigarette users, we present an evidence-based overview of the most important issues of e-cigarette use from a vascular medicine point of view. The key messages are presented as a position statement of the German Society of Vascular Medicine and endorsed by the European Society of Vascular Medicine.
No takes yet. Share an insight, caveat, or question.
Krabbe et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: